(Friday, 03 February 2012 20:43)
"Any partner who looks at this asset will back-load the payment because while the market is huge, we still don't know if the drug works the way we want," company's founder chairman told.
(Thursday, 29 December 2011 09:45)
The Indian Patents Office has appointed 94 design examiners to speed up the process of granting patents and clear a backlog of one lakh applications over the next three years.
(Friday, 23 December 2011 12:18)
BIOTECH companies producing industrial enzymes are gradually moving to cellulosic enzymes that help in bio-fuel generation.
(Wednesday, 23 November 2011 09:52)
Erythropoietin is a hormone produced by the kidney that promotes the formation of red blood cells in the bone marrow.
(Tuesday, 25 October 2011 10:24)
The decision to set up the centre, under UNESCO, was taken in the cabinet meeting headed by Prime Minister Manmohan Singh.
(Monday, 17 October 2011 07:41)
Mazumdar-Shaw said the size of the country's biotech sector had reached USD 3.5 billion in 2010 and is poised for robust growth in all segments of biotechnology.
(Tuesday, 20 September 2011 13:27)
Biotechnology major Biocon on Tuesday said it aims to achieve revenues of USD 1 billion in the next three years.
(Monday, 19 September 2011 03:44)
Chinese and Indian drugmakers have taken over much of the global trade in medicines and now manufacture more than 80 percent.
(Tuesday, 30 August 2011 14:25)
Vaccines, diagnostics and devices and personalised medicine are the key innovative growth areas for the domestic biotech sector.
(Monday, 29 August 2011 21:54)
However, bioethicists are getting increasingly concerned about recent research that is aimed at humanising animals in various ways.
(Monday, 01 August 2011 00:06)
The Uttarakhand biotechnology department has decided to set up a biotech park in the hill state in order to promote industries based on the technology.
(Tuesday, 26 July 2011 10:14)
Chaudhary Charan Singh Haryana Agricultural University(CCSHAU)-Hisar has been issued a patent on a biotechnological process.
(Sunday, 24 July 2011 19:37)
The deal is expected to be valued at Rs 300-450 cr and will boost Biochem's revenue growth. In fiscal 2009-10, Biochem reported revenues of Rs 241 cr.
(Thursday, 21 July 2011 08:52)
Biotech firm Biocon today said its subsidiary 'Syngene International' has entered into an agreement with US-based Endo Pharmaceuticals to expand their collaboration to develop molecules to fight cancer.
(Monday, 11 July 2011 08:47)
Life Technologies has invested around $3 million to open a distribution hub in Bangalore, which they expect would propel their business in India by 40% this year.
Close